The U.S. Institute of Medicine at the National Academy of Sciences recently released a new report on Countering the Problem of Falsified and Substandard Drugs. Commissioned by the U.S. Food and Drug Administration, it raises important, indeed frightening, concerns about the quality and reliability of medicines in the U.S. and other developed nations, as well as in low- and middle-income countries that often have weaker capacities, and proposes concrete steps in response.
CSIS wanted to learn more about how women leaders in Africa are bringing new attention to women’s health and empowerment in their own countries, and to bring those voices into the discussion about U.S. policy priorities for women’s global health. To do this, we sent a small team to Malawi and Zambia in December 2012.
The past two decades have seen a whirlwind of activity in emerging and re-emerging infectious diseases. Twenty years ago very few people talked about “One Health,” yet there is now strong consensus about the close links between animal and human health. Although it has been 60 years since Joshua and Esther Lederberg showed us that penicillin-resistant bacteria existed even before there was penicillin treatment, the problem of microbial resistance has accelerated over the past 20 years. And the scientific and public health community has shifted from talking about a “war” against microbes to a focus on better understanding microbial communities and on the interactions between hosts and microbes.
Botswana has made tremendous strides in the fight against HIV/AIDS in the last decade, supported by the early and important U.S. partnership created through the President’s Emergency Plan for AIDS Relief (PEPFAR). In the next five years, however, that partnership will be tested as the United States and Botswana negotiate a complex, multiyear handoff of PEPFAR-supported HIV/AIDS activities and as U.S. financial assistance is reduced. U.S. funding through PEPFAR is anticipated to decrease from $75 million to a plateau of $35 million by 2016, with an annual reduction in funding of about $10 million per year.
On November 30, Secretary of State Hillary Clinton launched the PEPFAR Blueprint: Creating an AIDS-free generation. We would like to extend our congratulations to her and Ambassador Goosby whose leadership enabled the successful completion of this difficult task in record time.
In the year leading up to the International AIDS Conference, CSIS played the unusual role of assembling a diverse high-level advisory group to assist the lead organizers in navigating the special challenges in the Washington political environment. That group, the American Friends of AIDS 2012, was especially important in enlarging the space for participation by Congressional and faith communities.
At its 28th meeting last week in Geneva, the Global Fund’s board approved a fundamental change in its funding model that’s designed to be flexible, focused, and fast. While significant details remain to be worked out, the basic approach has been agreed as has a plan to implement it rapidly.
Home to 170 million people, many of them desperately poor, Nigeria carries a huge and disproportionate share of burden for many of the world’s most deadly diseases. Look in the global strategies for HIV, TB, malaria, maternal and child health, polio eradication, NTDs, and NCDs – among many others – and you’ll see Nigeria at or near the top of the “Must Win” countries. The reason is simple. If there isn’t success in Nigeria, the global picture remains bleak.
Our understanding of global health and its relationship to national security, and the well-being of the wider global community has grown and evolved over time. For these reasons, health and security are no longer separate domains for policymakers. They interact with each other. In this project, CSIS explores the nexus between health and security by collecting personal stories of a selection of our nation's leading military and global health professionals.
While the economies of most rich nations have stagnated, many countries – which for decades had been classified as low income and regarded as chronically poor – have experience sustained growth and graduated into middle income status. This is overall a good news story. The bad news is that the emergence of new middle income states has also resulted in a growing disconnect between where international development assistance is focused and where it’s needed.
The process of rebuilding Liberia’s health system, shattered by 14 years of devastating conflict, is entering a crucial and potentially destabilizing phase. The Liberian government and local NGOs are assuming a larger responsibility, but Liberia’s health system is beset with serious problems. This report focuses on specific things the United States can do to sustain the momentum on public health in Liberia.
J. Stephen Morrison reflects on his four major impressions from AIDS 2012, including the strong reaffirmation of the United States' commitment to address HIV/AIDS and the international community's quest for an "AIDS Free Generation."